NAD+ supplementation limits triple-negative breast cancer metastasis via SIRT1-P66Shc signaling
Yi Jiang, Zongrui Luo, Yuanchao Gong, Yan Fu, Yongzhang Luo
Topics & Concepts
NAD+ kinaseCancer researchTriple-negative breast cancerBiologyBreast cancerSirtuinMetastasisCancerGene knockdownSIRT6Sirtuin 1Epithelial–mesenchymal transitionBiochemistryDownregulation and upregulationApoptosisGeneticsEnzymeGeneSirtuins and Resveratrol in MedicineAutophagy in Disease and TherapyCalcium signaling and nucleotide metabolism